A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 463.97
C 33.30
GOOG 609.09
BAC 7.97
RIMM 16.58

Recently Added

COHO 0.00
PZZI 5.46
AIMH 0.01
IDVC 0.35
BVSN 39.45

Gaining Speed

COHO 0.00
IDVC 0.35
AIMH 0.01
PZZI 5.46
BVSN 39.45
79.75 +0.87 (1.10%) ALXN

Click Here to Receive Instant E-mail and RSS Alerts


Trade ALXN now with

Stock Details

Last Trade:79.75 Change:+0.87 (1.10%) Prev Close:78.88 Open: 78.75 Days Range:78.20 – 80.08 52 Week Range: 43.78 - 105.00 Volume:897214 P/E: 99.69
EPS:0.80

Member Comments

No member comments available for ALXN


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/07/12

Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List

Goldman Sachs add Alexion Pharmaceuticals (NASDAQ: ALXN) to its Conviction Buy List with a price target of $91 (up from $83), suggesting 17% Upside The firm is calling ALXN "one of the most attractive stories in biotech." Goldman's analyst... Read More

Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Recent Alert on 02/03/12 at 7:50am
Goldman Sachs Adds Alexion Pharmaceuticals (ALXN) to Conviction Buy List
Recent Alert on 01/24/12 at 10:21am
Oppenheimer Boots Price Target On Alexion (ALXN) Following Asfotase Alfa Review
Recent Alert on 01/23/12 at 2:43pm
Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN) to $83

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 02/06/12 at 5:43pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Coissac Patrice
SEC Filing on 02/06/12 at 5:38pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Sinha Vikas
SEC Filing on 02/06/12 at 5:31pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Hallal David
SEC Filing on 02/06/12 at 5:26pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: DUBIN THOMAS I H
SEC Filing on 02/06/12 at 5:19pm
Form 4 ALEXION PHARMACEUTICALS For: Feb 03 Filed by: Carmichael Clare

View AllRecent Blog Posts

Blog Posts on 02/06/12 at 1:20pm
Alexion Pharmaceuticals: No Competition, A Solid Pipeline And Takeover Fever
Blog Posts on 02/03/12 at 4:09am
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Blog Posts on 02/03/12 at 2:10am
2 Biotech Stocks Leading This Rally
Blog Posts on 02/01/12 at 6:02pm
9 Biotechs Gaining Analyst Attention
Blog Posts on 01/30/12 at 5:50pm
11 Large-Cap, Low Debt Stocks For Defensive Investors